Ryan Zimmerman
Stock Analyst at BTIG
(4.09)
# 521
Out of 4,980 analysts
182
Total ratings
52.29%
Success rate
11.83%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SI Shoulder Innovations | Reiterates: Buy | $23 | $14.98 | +53.54% | 1 | Sep 9, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $39 | $20.45 | +90.71% | 8 | Aug 6, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $566 → $571 | $467.54 | +22.13% | 18 | Jul 23, 2025 | |
| RXST RxSight | Downgrades: Neutral | n/a | $9.78 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $59.08 | - | 15 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $32.54 | +102.83% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $287.09 | -5.95% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $90.91 | +63.90% | 10 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $392.76 | +0.32% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $1.50 | +566.67% | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $106 | $78.89 | +34.36% | 11 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $15.43 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $103.85 | +21.33% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $78.71 | +27.05% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $72.90 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $27.68 | +91.47% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.63 | +380.00% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.37 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.19 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.86 | +115.05% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.89 | +22.70% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.18 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.59 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $13.69 | +104.53% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $148.12 | +35.03% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $352.82 | -0.80% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $131.95 | -1.48% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $39.52 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $94.07 | +36.07% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.21 | +22.85% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $66.72 | +36.40% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.38 | +156.41% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.04 | +941.67% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.42 | - | 3 | Apr 2, 2020 |
Shoulder Innovations
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $14.98
Upside: +53.54%
OrthoPediatrics
Aug 6, 2025
Maintains: Buy
Price Target: $40 → $39
Current: $20.45
Upside: +90.71%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $566 → $571
Current: $467.54
Upside: +22.13%
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $9.78
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $59.08
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $32.54
Upside: +102.83%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $287.09
Upside: -5.95%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $90.91
Upside: +63.90%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $392.76
Upside: +0.32%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $78.89
Upside: +34.36%
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $15.43
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $103.85
Upside: +21.33%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $78.71
Upside: +27.05%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $72.90
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $27.68
Upside: +91.47%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.63
Upside: +380.00%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.37
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.19
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.86
Upside: +115.05%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $4.89
Upside: +22.70%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $6.18
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $14.59
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $13.69
Upside: +104.53%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $148.12
Upside: +35.03%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $352.82
Upside: -0.80%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $131.95
Upside: -1.48%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $39.52
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $94.07
Upside: +36.07%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.21
Upside: +22.85%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $66.72
Upside: +36.40%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $16.38
Upside: +156.41%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.04
Upside: +941.67%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $16.42
Upside: -